Versor Investments LP Takes $452,000 Position in Option Care Health, Inc. (NASDAQ:OPCH)

Versor Investments LP acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 19,500 shares of the company’s stock, valued at approximately $452,000.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Illinois Municipal Retirement Fund grew its position in Option Care Health by 114.2% in the fourth quarter. Illinois Municipal Retirement Fund now owns 34,460 shares of the company’s stock worth $799,000 after acquiring an additional 18,370 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new stake in shares of Option Care Health in the 4th quarter valued at $327,000. Olympiad Research LP bought a new stake in Option Care Health in the fourth quarter worth $360,000. New York State Common Retirement Fund boosted its holdings in Option Care Health by 14.6% in the fourth quarter. New York State Common Retirement Fund now owns 246,034 shares of the company’s stock worth $5,708,000 after purchasing an additional 31,400 shares in the last quarter. Finally, Kornitzer Capital Management Inc. KS increased its position in Option Care Health by 2.5% during the fourth quarter. Kornitzer Capital Management Inc. KS now owns 444,095 shares of the company’s stock worth $10,303,000 after buying an additional 10,900 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Up 0.9 %

OPCH opened at $33.50 on Monday. The business has a 50 day moving average of $28.70 and a 200-day moving average of $28.06. The stock has a market capitalization of $5.70 billion, a price-to-earnings ratio of 28.15, a P/E/G ratio of 2.30 and a beta of 1.35. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.17.

Analyst Upgrades and Downgrades

OPCH has been the subject of several recent analyst reports. Barrington Research upped their price target on Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research note on Thursday. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. UBS Group began coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Finally, Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $32.88.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.